Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Comment by somguyincanadaon Jan 14, 2013 12:41pm
169 Views
Post# 20835252

RE: RE: RE: Alamos buys Aurizon.........

RE: RE: RE: Alamos buys Aurizon.........

I'm sure that Alamos considered everything about Aurizon, including it's attractive joint venture with NOX (the 2nd year drilling results which they've hidden from us).

I am confident that Alamos will pick up the option.  Who would walk away from 2 million ounces (and this doesn't even include year 2 results ... which I'm sure would bring the total resource to over 3 million)?  Add in another fabulous year of drilling and we could see upwards of 4 million ouces of gold.  It's a no-brainer.

Now ... if Alamos abandons NOX, NOX pockets all the investment to date and goes at it alone. 

It's a win win scenario for NOX any way you look at it.  Today's trading agrees.

Remember folks, there are other big fish out there who would love to eat up NOX.  This is going to be the year of aquisitions!

NOX is so undervalued right now.  Now is the time to stock up. 

SGIC

 

 

<< Previous
Bullboard Posts
Next >>